24 FACTS MYFLIX DD
VERIFIABLE LINKS COMING (Work In
24 FACTS MYFLIX DD
VERIFIABLE LINKS COMING (Work In Process)
***CONSUMER SITE NOW BEING FINALIZED "OFF-LINE" & LAUNCHING WITHIN WEEKS!***
https://myflix.com/
1.) 15,000 Movies
2.) 44 Distinct Supplier Companies
3.) Pay Per View Transaction
4.) Monthly Subscription
5.) Form 10 Registration File
6.) S-1 Registration File
7.) Up To 50,000 @ .03 Per Share = $1,500,000
8.) Launch 1 - Q-1 2021 - Feature Films + Television Shows
9.) Up To 50,000 @ .05 Per Share = $2,500,000
10.) Launch 2 - Q-1 2021 - Single Player + Interactive Gaming
11.) Up To 50,000 @ .08 Per Share (IF NEEDED) = $4,000,000
12.) Launch 3 - Q-2 2021 - Educational Programming
1-12 Common Knowledge any investor easily DD. I will provide further DD Links.
13.) S-1 Funds like Off The Shelf, New Shares Sold by HHSE. The ($1.5M, $2.5M, Or $4M goes Directly into HHSE Treasury. Planned Spending MYFLIX 67%, Debt & Payables 33%.
(First Chart)
https://hannoverhousemovies.blogspot.com/search?q=myflix
14.) Business Model for MyFlix is to consolidate feature films and television series programming owned by a wide range of studios and content owners, into a single destination digital streaming site.
https://myflix.com/
15.) Revenue Model for MyFlix will be to pay third-party streaming and billing costs off the top and divide remaining revenues on a fifty-fifty basis between the program suppliers and with Vodwiz / MyFlix.
10-Q - Page 3:
https://www.sec.gov/Archives/edgar/data/10696...orm10q.htm
16.) Over 8,000 of 15,000 Titles are not currently available for streaming into North America through any other site... giving MyFlix the promotional ability to tout that the site has "thousands of movies not available through any other site," which could be welcomed news for consumers facing Netflix fatigue.
(Strategic Overview for Launch of Myflix.com and the Myflix Over-the-top (OTT) APP Portal)
https://hannoverhousemovies.blogspot.com/search?q=myflix
17.) Utilizing the Best-Functioning Elements of the Netflix Subscription and Amazon Prime Transactional Models for In-Home Delivery of Content, Myflix Builds on the Concept of “WATCH WHAT YOU WANT, WHEN YOU WANT IT” by Offering Literally Thousands of Films and Programs That are Otherwise Not Available for Viewing on any Other Streaming Platforms or OTT App Sites.
18.) As the venture grew, we found that three major studio labels were willing to "give VODWIZ a try" by offering an assortment of higher-end theatrical titles... so the venture was becoming MORE than a site solely for lesser-known, independent movies.
19.) HHSE Previous Distribution Model Tied-up a lot of working capital. The company is basically moving AWAY from a cash-intensive model, and into a "fast-cash flow" delivery model. The company's cash flow IMPROVES under such a digital-streaming distribution model.
20.) VODWIZ / MYFLIX Presents: Three Steps to a POWERFUL Marketing Angle & Position "Watch - Learn - Play"
21.) Myflix will be accessible to consumers either as a direct internet URL (www.Myflix.com), or as a Myflix OTT App, which Myflix managers will begin to aggressively promote as a “pre-installed” app for ROKU, APPLE, SONY, LG and other manufacturers of OTT Devices and Internet friendly DVD / Blu-Ray players.
22.) Our initial (first year) Target is to have 100,000 subscription customers, averaged at $8.50 per month - for annualized gross revenues of $10,200,000.
23.) The operational system we are building with Amazon will accommodate data servicing for up to 50-million monthly subscriptions, should the venture prove to be widely popular!
24.) MYFLIX GROWTH - With a monthly break-even of only 12,000 subscribers (at $8 each) or 30,000 total TVOD Transactions (or a mixture of both revenue streams), MyFlix is anticipated to be Cash-Flow Positive within 90-days of initial consumer launch. Comparable sites, such as Acorn.TV have over 700,000 monthly subscribers (generating almost $100-mm per year in gross subscription revenues). So, we are optimistic that MyFlix has the potential to be a major venture and cash-flow generator for HHSE.
Hannover House Inc. (HHSE) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...
Continue Reading
Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...
Continue Reading
The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Top 5 Most Recently Viewed Articles
Introduction to the Crawford Nickel Project Canada Nickel Company Inc. has exciting news regarding its Crawford Nickel Project, which has been officially recognized by the Province of Ontario. This milestone comes as part of Ontario's One Project, One Process (1P1P) framework, a major step forward for the mining sector. Understanding the One Project, One Process Framework...
Continue Reading
TeamBridge Secures $28 Million to Revolutionize the Hourly Workforce TeamBridge, a rapidly expanding Workforce Operating System (Workforce OS), has successfully raised $28 million in Series B funding. This round was led by Mayfield, with considerable backing from existing investors, including General Catalyst and Abstract Ventures. This funding represents a significant...
Continue Reading
Pierre Fabre Laboratories and Iktos Unite for Oncology Drug Discovery Pierre Fabre Laboratories and Iktos have announced an exciting new collaboration aimed at transforming drug discovery in oncology. This partnership harnesses the strengths of both companies to utilize advanced AI technologies for developing new small-molecule drug candidates. Together, they plan to make...
Continue Reading
Vitamin Angels and Walgreens: A Transformative Partnership Vitamin Angels and Walgreens have reached a remarkable achievement, positively impacting the lives of 500 million women and children across the globe. Over the course of their partnership, they have dedicated themselves to providing essential vitamins and minerals primarily to underserved communities within the...
Continue Reading
Understanding the Flourishing Fluoropolymer Market in India India's fluoropolymer market is on an impressive trajectory, forecasted to reach a valuation of US$ 799.28 million by 2033 from US$ 425.12 million in 2024, reflecting an annual growth rate (CAGR) of 7.46% during the years ahead. This surge can be attributed to various factors, including technological...
Continue Reading